Book Reviews

Jeffrey T. Richelson and Desmond Ball, The Ties that Bind: Intelligence Cooperation between the UKUSA Countries (London: George Allen &; Unwin 1986). Pp. xviii + 402. £19.95.

Giuseppe De Lutiis, Storia dei Servizi Segreti in Italia (Rome: Editori Riuniti, 1985). Pp. 313, Lire 16,500.

Scott D. Breckenridge, The CIA and the U.S. Intelligence System (Boulder, CO; Westview Press, Frederick A. Praeger). Pp. 364.

Phillip Thurmond Smith, Policing Victorian London. Political Policing, Public Order, and the London Metropolitan Police (Westport, CT and London: Greenwood Press, 1985). Pp. x + 230. £35.

Charles Perrow, Normal Accidents: Living with High‐Risk Technologies (New York: Basic Books, 1984). Pp. 386. $10.95.     

New frontiers in criminal careers research, 2000-2011: A state-of-the-art review

Purpose

The criminal career paradigm is a major research focus in criminology, and the current state-of-the-art review explicates research published between 2000 and 2011.

Materials and methods

Keyword searches of Science Direct, Scopus, and the National Criminal Justice Research Service produced 364 studies on criminal careers.

Results

A narrative meta-review summarizes essential findings on the parameters of the criminal career, investigates emerging theoretical and disciplinary extensions that utilize the criminal career framework, and identifies 16 pressing research gaps.

Conclusions

Although the study of criminal careers has been a dominant research area in criminology, its presence is likely to expand as research becomes more interdisciplinary and a longitudinal, biosocial perspective takes hold in the criminological sciences.     

Advances in Biometric Encryption: Taking Privacy by Design from Academic Research to Deployment

An organization should address ethical issues including privacy before deploying biometric systems. Threats to informational privacy rights related to potential data misuse, function creep, and the data linkage of personal information contained in diverse databases makes possible such unintended consequences as surveillance, profiling, and discrimination. Unlike passwords, biometric data are unique, irrevocable, and variable. Biometric encryption (BE) is highlighted as a prominent example of Privacy by Design, where privacy is embedded as a core functionality in the biometric system. BE binds a digital key to (or extracts the key from) the biometrics. Earlier technical challenges to this new technology, as well as recent advances, are presented. Lastly, an overview is provided of an application using facial recognition (FR) in a watch list scenario, known to be the first and largest successful deployment of BE using FR, in a casino context.     

Transgender Marriage and the Legal Obligation to Disclose Gender History

Section 12 of the Matrimonial Causes Act 1973 as amended by the Gender Recognition Act 2004 requires transgender people to disclose their ‘gender history’ to the other party to a marriage prior to the marriage ceremony. Failure to do so enables the other party to exit the relationship through nullity proceedings. This article argues that this provision is discriminatory and encroaches on the right to privacy, breaching Articles 14 and 8 of the European Convention on Human Rights. It challenges the idea, implicit in the provision, that non‐disclosure of gender history is unethical or fraudulent. Crucially, the article considers and rejects the claim that discrimination against and encroachments on the privacy of transgender people are justified because inadvertent sexual congress with a transgender person is potentially harmful. Finally, if a consent‐based right to know exists, it argues that it ought to be trumped by considerations of justice, legal consistency and public policy.     

The legal landscape for advanced therapies: material and institutional implementation of European Union rules in France and the United Kingdom

In 2007, the European Union adopted a lex specialis, Regulation (EC) No. 1394/2007 on advanced therapy medicinal products (ATMPs), a new legal category of medical product in regenerative medicine. The regulation applies to ATMPs prepared industrially or manufactured by a method involving an industrial process. It also provides a hospital exemption, which means that medicinal products not regulated by EU law do not benefit from a harmonized regime across the European Union but have to respect national laws. This article describes the recent EU laws, and contrasts two national regimes, asking how France and the United Kingdom regulate ATMPs which do and do not fall under the scope of Regulation (EC) No. 1394/2007. What are the different legal categories and their enforceable regimes, and how does the evolution of these highly complex regimes interact with the material world of regenerative medicine and the regulatory bodies and socioeconomic actors participating in it?